Revance Historical Income Statement
RVNC Stock | USD 3.73 0.11 2.86% |
Historical analysis of Revance income statement accounts such as Other Operating Expenses of 578.4 M, Research Development of 77.3 M, Cost Of Revenue of 159.8 M or Total Operating Expenses of 418.6 M can show how well Revance performed in making a profits. Evaluating Revance income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Revance's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Revance latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Revance is a good buy for the upcoming year.
Revance |
About Revance Income Statement Analysis
Revance Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Revance shareholders. The income statement also shows Revance investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Revance Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Revance generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Revance. It is also known as Revance overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Revance income statement and represents the costs associated with goods and services Revance provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Most accounts from Revance's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Revance current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.At present, Revance's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 86 M, whereas Depreciation And Amortization is forecasted to decline to about 8 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 6.3M | 16.5M | 19.4M | 20.3M | Depreciation And Amortization | 19.9M | 33.7M | 13.7M | 8.0M |
Revance income statement Correlations
Click cells to compare fundamentals
Revance Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Revance income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 2.9M | 10.3M | 19.9M | 33.7M | 13.7M | 8.0M | |
Interest Expense | 2.1M | 15.1M | 6.3M | 16.5M | 19.4M | 20.3M | |
Total Revenue | 413K | 15.3M | 77.8M | 132.6M | 234.0M | 245.7M | |
Gross Profit | (102.4M) | 10.6M | 54.4M | 80.9M | 81.9M | 86.0M | |
Other Operating Expenses | 164.9M | 288.5M | 352.5M | 404.7M | 550.8M | 578.4M | |
Operating Income | (164.5M) | (273.2M) | (274.7M) | (272.2M) | (316.8M) | (300.9M) | |
Ebit | (162.1M) | (269.6M) | (275.0M) | (339.2M) | (304.3M) | (289.1M) | |
Research Development | 102.9M | 125.8M | 116.3M | 101.3M | 79.4M | 77.3M | |
Ebitda | (159.2M) | (259.3M) | (255.2M) | (305.5M) | (290.6M) | (276.1M) | |
Cost Of Revenue | 102.9M | 4.8M | 23.4M | 51.7M | 152.2M | 159.8M | |
Total Operating Expenses | 164.9M | 283.7M | 329.1M | 353.1M | 398.7M | 418.6M | |
Income Before Tax | (159.4M) | (284.7M) | (281.3M) | (355.7M) | (323.7M) | (307.5M) | |
Total Other Income Expense Net | 5.0M | (11.5M) | (6.6M) | (13.8M) | (6.9M) | (6.6M) | |
Net Income | (156.2M) | (282.1M) | (286.8M) | (356.4M) | (324.0M) | (307.8M) | |
Income Tax Expense | (3.2M) | (2.6M) | 5.5M | 700K | 300K | 285K | |
Selling General Administrative | 62.0M | 149.7M | 28.3M | 4.2M | 38.8M | 45.9M | |
Net Income From Continuing Ops | (159.4M) | (282.1M) | (281.3M) | (356.4M) | (414.2M) | (393.5M) | |
Non Operating Income Net Other | 3.1M | 5.0M | 3.6M | (361K) | (415.2K) | (394.4K) | |
Net Income Applicable To Common Shares | (159.4M) | (282.1M) | (281.3M) | (356.4M) | (320.8M) | (304.7M) | |
Interest Income | 5.5M | 4.3M | 337K | 4.9M | 12.9M | 13.5M | |
Net Interest Income | 5.5M | (10.8M) | (5.9M) | (11.6M) | (4.8M) | (4.6M) | |
Reconciled Depreciation | 2.9M | 10.3M | 19.9M | 27.8M | 30.7M | 32.2M | |
Tax Provision | 100K | (2.6M) | (2.7M) | 700K | 300K | 315K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Revance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Revance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Revance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Revance Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.34) | Revenue Per Share 2.656 | Quarterly Revenue Growth 0.107 | Return On Assets (0.24) | Return On Equity (20.97) |
The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.